Comments
Loading...

Aprea Therapeutics Stock Guidance

APRENASDAQ
Logo brought to you by Benzinga Data
$2.19
-0.07-3.10%
At close: -
$2.35
0.167.31%
After Hours: 5:18 PM EDT
Q4 2024 earnings were released today before the market open

Aprea Therapeutics Stock Guidance | NASDAQ:APRE | Benzinga

Aprea Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Aprea Therapeutics Inc (APRE) does not provide guidance data

FAQ

Q

What is the most recent guidance for Aprea Therapeutics (APRE)?

A

There have been no specific sales or earnings guidance reported for Aprea Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch